SITEMAP

Overview
Management
Stock Quote
Stock Chart
Financial Reports
Audio Archives
Earnings Estimates
Fundamentals
SEC Filings
Insider Transactions
News Releases
Presentations & CEO Updates
Calendar
Email Alerts
Request Info
Risk Factors
Corporate Governance

Highlights | Management & Directors | Committee Composition |



Allan Ferguson
Director

Allan Ferguson became a director of Biopure in April 2007. He brings to the board over 25 years of operating and management experience in engineering, manufacturing, and research and development, and 20 years of experience in international venture capital investing with life science and technology companies.

Ferguson is also a director of Autoimmune Inc., TransMedics Inc., Ulthera Inc., Xthetix Inc., and ZONARE Medical Systems. He recently retired as a senior partner of 3i's Venture Capital Group, where he headed up the firm's U.S. operation that he helped start. He previously served as a Biopure board member from December 1988 to December 1990, in connection with 3i's investment in the company.